Attenuation of kainic acid-induced status epilepticus by inhibition of endocannabinoid transport and degradation in guinea pigs

Epilepsy Research
Liubov ShubinaValentina Kitchigina

Abstract

Status epilepticus (SE) is a medical emergency associated with a high rate of mortality if not treated promptly. Exogenous and endogenous cannabinoids have been shown to possess anticonvulsant properties both in vivo and in vitro. Here we study the influence of endocannabinoid metabolism on the development of kainic acid-induced SE in guinea pigs. For this purpose, the inhibitors of endocannabinoid transport, AM404, and enzymatic (fatty acid amide hydrolase) degradation, URB597, were applied. Cannabinoid CB1 receptor antagonist, AM251, was also tested. Animal behavior as well as local electric field potentials in four structures: medial septum, hippocampus, entorhinal cortex and amygdala were analyzed when AM404 (120nmol), URB597 (4.8nmol) or AM251 (20nmol) were administrated alone or together with 0.4μg of kainic acid. All substances were injected i.c.v. AM404, URB597 or AM251 administered alone did not alter markedly local field potentials of all four studied structures in the long-term compared with their basal activity. AM404 and URB597 significantly alleviated kainic acid-induced SE, decreasing behavioral manifestations, duration of seizure events and SE in general without changing the amplitude of local field potentials. ...Continue Reading

References

Mar 1, 1972·Electroencephalography and Clinical Neurophysiology·R J Racine
Dec 16, 1998·Annals of Neurology·D C HesdorfferW A Hauser
Mar 24, 2000·Naunyn-Schmiedeberg's Archives of Pharmacology·A Ameri, T Simmet
Nov 14, 2000·Trends in Neurosciences·Y Ben-Ari, R Cossart
Jan 10, 2002·European Journal of Pharmacology·M J WallaceR J DeLorenzo
Jul 20, 2002·Neuropharmacology·S N DaviesG Riedel
Jul 5, 2003·Physiological Reviews·P SahJ Power
Sep 5, 2003·The Journal of Pharmacology and Experimental Therapeutics·Melisa J WallaceRobert J DeLorenzo
Oct 1, 2003·British Journal of Pharmacology·Ruth A Ross
Oct 4, 2003·Science·Giovanni MarsicanoBeat Lutz
Apr 14, 2004·The European Journal of Neuroscience·Leonid G KhaspekovBeat Lutz
Jul 28, 2004·Neuropharmacology·Hamed ShafaroodiAhmad Reza Dehpour
Jun 14, 2005·Neuropharmacology·Kristen A SlaninaPaul Schweitzer
Aug 27, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·David A KaranianBen A Bahr
Nov 23, 2006·Nature Neuroscience·David RobbeGyörgy Buzsaki
Dec 19, 2006·European Journal of Pharmacology·Laxmikant S DeshpandeRobert J DeLorenzo
Jan 5, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kang ChenIvan Soltesz
Jun 5, 2007·The Journal of Pharmacology and Experimental Therapeutics·David A KaranianBen A Bahr
Jun 17, 2008·Brain : a Journal of Neurology·Fabrice BartolomeiFabrice Wendling
Jul 22, 2008·Neuroscience Letters·Irina Yu PopovaValentina F Kitchigina
Sep 9, 2008·Nature Medicine·István Katona, Tamás F Freund
Jun 30, 2009·Frontiers in Integrative Neuroscience·Rob Mason, Joseph F Cheer
Aug 27, 2009·Epilepsia·Hilde M H BraakmanMarc C T F M de Krom
Nov 12, 2010·Journal of Molecular Neuroscience : MN·Vinogran NaidooBen A Bahr
Mar 29, 2011·Pharmacological Reports : PR·Clementina M van RijnGilles van Luijtelaar

❮ Previous
Next ❯

Citations

Feb 20, 2016·Clinical Drug Investigation·Alberto VerrottiFilomena Fezza
Aug 19, 2015·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Evan C RosenbergOrrin Devinsky
Dec 14, 2019·Nature Reviews. Neurology·Luigia CristinoVincenzo Di Marzo
Jan 3, 2020·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·Anna-Maria SmolyakovaRobert B Laprairie
Jan 11, 2020·Frontiers in Cellular Neuroscience·Soraya Wilke SalibaBernd L Fiebich
Oct 8, 2020·International Journal of Molecular Sciences·Diogo M LourençoSara Xapelli
Apr 24, 2021·ACS Chemical Neuroscience·Alessandro GrilloGiuseppe Di Giovanni
Nov 7, 2021·Neurotoxicity Research·Karen Jaqueline Paredes-RuizAna Laura Colín-González

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.